Ark Health Review
Best for: Buyers seeking the **broadest single-platform product menu** (compounded + brand + non-GLP-1 wellness adjuncts like Sermorelin and MIC/B12 all under one account) who can tolerate the transparency gaps (no states list, no LegitScript ID, no named pharmacy partner). NOT recommended for buyers seeking brand Ozempic/Mounjaro — direct manufacturer channels (NovoCare, LillyDirect) are 2-3× cheaper. Best value tier is the compounded oral sema at $125/mo. Note: states-served gap means buyers should call (855) 758-2275 to confirm coverage before signing up.
Ark Health (tryark.com) is a national direct-to-consumer GLP-1 telehealth platform offering an unusually **broad product menu** — compounded semaglutide injection ($169/mo discounted), compounded tirzepatide injection ($249/mo discounted), compounded oral semaglutide ($125/mo discounted), brand Ozempic ($1,399/mo cash), brand Mounjaro ($1,499/mo cash), plus injectable Sermorelin ($220/mo) and injectable MIC/B12 ($220/mo). Brand cash pricing is significantly higher than direct pharmacy/coupon channels — DTC brand pricing through Ark Health is NOT competitive with NovoCare or LillyDirect. Compounded tier is the value play. **'100% online consultations with certified healthcare providers'** — sync vs async not explicitly stated. Verbatim marketing claims: 'Free expedited shipping,' 'Consistent pricing at all dosages,' 'No hidden fees,' 'Continuous support and follow-ups.' Phone: (855) 758-2275. Email: support@tryark.com. Significant gaps in public disclosure: states served NOT enumerated, LegitScript certification ID NOT visible, verbatim FDA compounded-medication disclaimer NOT displayed on homepage/FAQ, named medical director NOT disclosed, pharmacy partner (503A/503B) NOT named, HSA/FSA eligibility NOT confirmed, corporate legal entity NOT specified, corporate address NOT provided, refund/cancellation policy linked but text not surfaced on browseable pages. Live-verified 2026-05-20.
Medium confidence · Last verified 2026-05-20 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Ark Health is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Ark Health prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| All doses (discounted standard) | compounded | $169 |
| All doses (discounted standard) | compounded | $249 |
| All doses (discounted standard, oral) | compounded-oral | $125 |
| Brand Ozempic cash (DTC markup) | brand | $1399 |
| Brand Mounjaro cash (DTC markup) | brand | $1499 |
✓ Pros
- •**Broadest product menu in the directory** — compounded sema injection + compounded tirz injection + compounded oral sema + brand Ozempic + brand Mounjaro + Sermorelin + MIC/B12 all under one platform. Buyers wanting optionality (try compounded, switch to brand, add adjuncts) can stay within one telehealth account.
- •**'Consistent pricing at all dosages'** — flat-rate model removes per-tier price escalation as patients titrate up (typical DTC pattern is $99→$200+ as dose increases)
- •Compounded oral semaglutide at $125/mo is competitively priced for the oral-tier niche (most DTC providers do not offer oral compounded sema)
- •Free expedited shipping included
- •Phone support published (uncommon among DTC platforms)
✗ Cons
- •**States served NOT publicly enumerated** — buyers cannot confirm coverage in their state without contacting support. This is a CRITICAL transparency gap.
- •**LegitScript certification status NOT disclosed** — no badge or verifiable ID visible on homepage/FAQ. Cannot independently confirm compliance posture.
- •**Verbatim FDA compounded-medication disclaimer NOT displayed** on homepage/FAQ — falls short of FDA guidance + WLR transparency standard
- •**Named medical director / clinical lead NOT disclosed** — only 'certified healthcare providers' generic
- •**Pharmacy partner NOT named** — 503A vs 503B compounding designation unspecified. Cannot trace supply chain.
- •**Brand Ozempic ($1,399) and Mounjaro ($1,499) DTC cash pricing significantly markup vs direct channels** — NovoCare Ozempic baseline is $499/mo without insurance for cash buyers; LillyDirect Zepbound is $349-$549/mo. Buying brand drugs through Ark Health DTC is materially more expensive than direct manufacturer/pharmacy channels.
- •Corporate legal entity (LLC/Inc/PC) NOT disclosed
- •Corporate address NOT provided
- •Refund/cancellation policy linked but text not surfaced on browseable pages
- •HSA/FSA eligibility NOT confirmed
- •Synchronous vs asynchronous telehealth model NOT explicitly stated
Ready to start with Ark Health?
Starting at $125/month. See current pricing and start your free consultation.
Sources & methodology
Our Ark Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Ark Health
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Ark Health?
Starting at $125/month. See current pricing and start your free consultation.